# Pfizer Inc. (PFE) — Q3-2014 Earnings Results

**Report date:** 2014-10-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q3-2014

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 0.21%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.57 | N/A | +2.70% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future prospects. They emphasized the importance of their product pipeline.

**Key quotes:**

> Management highlighted ongoing product development and market opportunities.

> They expressed confidence in the company's pipeline despite not providing specific guidance.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Pfizer's earnings report showed a positive surprise in EPS, which contributed to a slight increase in the stock price. The lack of revenue details and guidance may leave some investors cautious, but management's focus on product development suggests potential growth opportunities ahead.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q3-2014_